Biomerica, Inc. (BMRA)
USD 0.51
(-4.89%)
USD 0.51
(-4.89%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 2.66 Million USD | -2.45% |
| 2023 | 2.73 Million USD | -10.48% |
| 2022 | 3.04 Million USD | 17.66% |
| 2021 | 2.59 Million USD | -14.93% |
| 2020 | 3.04 Million USD | 140.97% |
| 2019 | 1.26 Million USD | 40.99% |
| 2018 | 896.8 Thousand USD | 69.57% |
| 2017 | 528.86 Thousand USD | 4.51% |
| 2016 | 506.02 Thousand USD | -3.42% |
| 2015 | 523.93 Thousand USD | -5.74% |
| 2014 | 555.84 Thousand USD | -0.72% |
| 2013 | 559.89 Thousand USD | -5.47% |
| 2012 | 592.28 Thousand USD | -5.24% |
| 2011 | 625.01 Thousand USD | -34.37% |
| 2010 | 952.3 Thousand USD | 18.43% |
| 2009 | 804.08 Thousand USD | -34.29% |
| 2008 | 1.22 Million USD | -16.86% |
| 2007 | 1.47 Million USD | 7.87% |
| 2006 | 1.36 Million USD | -39.56% |
| 2005 | 2.25 Million USD | 9.9% |
| 2004 | 2.05 Million USD | -10.76% |
| 2003 | 2.3 Million USD | 16.21% |
| 2002 | 1.98 Million USD | 8.41% |
| 2001 | 1.82 Million USD | -0.01% |
| 2000 | 1.82 Million USD | 14.22% |
| 1999 | 1.6 Million USD | 23.08% |
| 1998 | 1.3 Million USD | -13.33% |
| 1997 | 1.5 Million USD | -25.0% |
| 1996 | 2 Million USD | -23.08% |
| 1995 | 2.6 Million USD | -13.33% |
| 1994 | 3 Million USD | -14.29% |
| 1993 | 3.5 Million USD | -14.63% |
| 1992 | 4.1 Million USD | -14.58% |
| 1991 | 4.8 Million USD | 9.09% |
| 1990 | 4.4 Million USD | 780.0% |
| 1989 | 500 Thousand USD | -28.57% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 2.66 Million USD | -2.45% |
| 2024 Q4 | 2.66 Million USD | 5.09% |
| 2024 Q3 | 2.53 Million USD | 3.51% |
| 2024 Q1 | 2.45 Million USD | -10.22% |
| 2024 Q2 | 2.44 Million USD | -0.12% |
| 2023 Q2 | 2.66 Million USD | -2.34% |
| 2023 Q1 | 2.72 Million USD | -10.53% |
| 2023 FY | 2.73 Million USD | -10.48% |
| 2023 Q4 | 2.73 Million USD | 22.75% |
| 2023 Q3 | 2.22 Million USD | -16.53% |
| 2022 Q1 | 2.71 Million USD | 4.68% |
| 2022 Q4 | 3.04 Million USD | -60.92% |
| 2022 FY | 3.04 Million USD | 17.66% |
| 2022 Q2 | 5.9 Million USD | 117.76% |
| 2022 Q3 | 7.8 Million USD | 32.07% |
| 2021 Q4 | 2.59 Million USD | -5.69% |
| 2021 FY | 2.59 Million USD | -14.93% |
| 2021 Q1 | 3.31 Million USD | 8.7% |
| 2021 Q2 | 3.32 Million USD | 0.51% |
| 2021 Q3 | 2.74 Million USD | -17.45% |
| 2020 FY | 3.04 Million USD | 140.97% |
| 2020 Q1 | 3.1 Million USD | 145.19% |
| 2020 Q2 | 3.66 Million USD | 18.14% |
| 2020 Q3 | 3.53 Million USD | -3.51% |
| 2020 Q4 | 3.04 Million USD | -13.79% |
| 2019 Q1 | 797.53 Thousand USD | -11.07% |
| 2019 Q3 | 1.11 Million USD | 9.51% |
| 2019 FY | 1.26 Million USD | 40.99% |
| 2019 Q4 | 1.26 Million USD | 13.56% |
| 2019 Q2 | 1.01 Million USD | 27.49% |
| 2018 Q1 | 626.71 Thousand USD | 18.5% |
| 2018 Q4 | 896.8 Thousand USD | 18.11% |
| 2018 Q3 | 759.29 Thousand USD | -5.61% |
| 2018 Q2 | 804.39 Thousand USD | 28.35% |
| 2018 FY | 896.8 Thousand USD | 69.57% |
| 2017 Q4 | 528.86 Thousand USD | -19.47% |
| 2017 FY | 528.86 Thousand USD | 4.51% |
| 2017 Q1 | 444.91 Thousand USD | -12.08% |
| 2017 Q2 | 566.51 Thousand USD | 27.33% |
| 2017 Q3 | 656.74 Thousand USD | 15.93% |
| 2016 Q4 | 506.02 Thousand USD | 3.94% |
| 2016 Q3 | 486.84 Thousand USD | 3.78% |
| 2016 Q2 | 469.08 Thousand USD | -12.99% |
| 2016 FY | 506.02 Thousand USD | -3.42% |
| 2016 Q1 | 539.14 Thousand USD | 2.9% |
| 2015 FY | 523.93 Thousand USD | -5.74% |
| 2015 Q2 | 466.99 Thousand USD | 33.91% |
| 2015 Q4 | 523.93 Thousand USD | 8.39% |
| 2015 Q3 | 483.37 Thousand USD | 3.51% |
| 2015 Q1 | 348.72 Thousand USD | -37.26% |
| 2014 FY | 555.84 Thousand USD | -0.72% |
| 2014 Q4 | 555.84 Thousand USD | 2.28% |
| 2014 Q2 | 400.59 Thousand USD | -25.33% |
| 2014 Q1 | 536.5 Thousand USD | -4.18% |
| 2014 Q3 | 543.45 Thousand USD | 35.66% |
| 2013 Q2 | 545.68 Thousand USD | -23.17% |
| 2013 Q1 | 710.26 Thousand USD | 19.92% |
| 2013 FY | 559.89 Thousand USD | -5.47% |
| 2013 Q4 | 559.89 Thousand USD | -4.14% |
| 2013 Q3 | 584.1 Thousand USD | 7.04% |
| 2012 Q3 | 662.63 Thousand USD | 56.98% |
| 2012 Q1 | 523.56 Thousand USD | -16.23% |
| 2012 FY | 592.28 Thousand USD | -5.24% |
| 2012 Q2 | 422.12 Thousand USD | -19.37% |
| 2012 Q4 | 592.28 Thousand USD | -10.62% |
| 2011 FY | 625.01 Thousand USD | -34.37% |
| 2011 Q1 | 823.04 Thousand USD | -13.57% |
| 2011 Q2 | 722.2 Thousand USD | -12.25% |
| 2011 Q3 | 715.47 Thousand USD | -0.93% |
| 2011 Q4 | 625.01 Thousand USD | -12.64% |
| 2010 Q2 | 832.13 Thousand USD | 3.46% |
| 2010 Q1 | 804.28 Thousand USD | 0.03% |
| 2010 FY | 952.3 Thousand USD | 18.43% |
| 2010 Q3 | 896.36 Thousand USD | 7.72% |
| 2010 Q4 | 952.3 Thousand USD | 6.24% |
| 2009 Q1 | 1.09 Million USD | -10.49% |
| 2009 Q4 | 804.08 Thousand USD | -20.56% |
| 2009 FY | 804.08 Thousand USD | -34.29% |
| 2009 Q2 | 1.06 Million USD | -2.49% |
| 2009 Q3 | 1.01 Million USD | -5.24% |
| 2008 Q2 | 1.31 Million USD | 3.71% |
| 2008 Q3 | 1.2 Million USD | -8.58% |
| 2008 Q4 | 1.22 Million USD | 1.92% |
| 2008 FY | 1.22 Million USD | -16.86% |
| 2008 Q1 | 1.26 Million USD | -13.97% |
| 2007 Q2 | 1.42 Million USD | 1.91% |
| 2007 Q4 | 1.47 Million USD | 1.37% |
| 2007 Q1 | 1.39 Million USD | 2.22% |
| 2007 FY | 1.47 Million USD | 7.87% |
| 2007 Q3 | 1.45 Million USD | 2.16% |
| 2006 Q4 | 1.36 Million USD | -8.58% |
| 2006 Q1 | 2.15 Million USD | -4.71% |
| 2006 Q2 | 2.83 Million USD | 31.63% |
| 2006 Q3 | 1.49 Million USD | -47.29% |
| 2006 FY | 1.36 Million USD | -39.56% |
| 2005 Q3 | 2.44 Million USD | -1.29% |
| 2005 FY | 2.25 Million USD | 9.9% |
| 2005 Q2 | 2.47 Million USD | 12.18% |
| 2005 Q1 | 2.2 Million USD | 7.38% |
| 2005 Q4 | 2.25 Million USD | -7.58% |
| 2004 Q3 | 2.46 Million USD | 7.1% |
| 2004 FY | 2.05 Million USD | -10.76% |
| 2004 Q2 | 2.29 Million USD | -0.35% |
| 2004 Q1 | 2.3 Million USD | 0.14% |
| 2004 Q4 | 2.05 Million USD | -16.5% |
| 2003 Q3 | 1.97 Million USD | 4.21% |
| 2003 Q1 | 1.69 Million USD | -14.56% |
| 2003 Q2 | 1.89 Million USD | 11.91% |
| 2003 Q4 | 2.3 Million USD | 16.63% |
| 2003 FY | 2.3 Million USD | 16.21% |
| 2002 Q1 | 2.27 Million USD | 24.6% |
| 2002 Q2 | 2.08 Million USD | -8.54% |
| 2002 Q3 | 2.18 Million USD | 4.93% |
| 2002 Q4 | 1.98 Million USD | -9.33% |
| 2002 FY | 1.98 Million USD | 8.41% |
| 2001 Q2 | 2.31 Million USD | -3.77% |
| 2001 Q4 | 1.82 Million USD | -9.54% |
| 2001 Q3 | 2.01 Million USD | -12.89% |
| 2001 FY | 1.82 Million USD | -0.01% |
| 2001 Q1 | 2.4 Million USD | 31.84% |
| 2000 FY | 1.82 Million USD | 14.22% |
| 2000 Q1 | 1.6 Million USD | 0.0% |
| 2000 Q2 | 1.7 Million USD | 6.25% |
| 2000 Q4 | 1.82 Million USD | 4.33% |
| 2000 Q3 | 1.75 Million USD | 3.04% |
| 1999 Q3 | 1.5 Million USD | 0.0% |
| 1999 Q4 | 1.6 Million USD | 6.67% |
| 1999 Q2 | 1.5 Million USD | 0.0% |
| 1999 Q1 | 1.5 Million USD | 15.38% |
| 1999 FY | 1.6 Million USD | 23.08% |
| 1998 Q4 | 1.3 Million USD | -13.33% |
| 1998 FY | 1.3 Million USD | -13.33% |
| 1998 Q1 | 1.5 Million USD | 0.0% |
| 1998 Q2 | 1.7 Million USD | 13.33% |
| 1998 Q3 | 1.5 Million USD | -11.76% |
| 1997 Q1 | 2 Million USD | 0.0% |
| 1997 FY | 1.5 Million USD | -25.0% |
| 1997 Q4 | 1.5 Million USD | -25.0% |
| 1997 Q3 | 2 Million USD | 0.0% |
| 1997 Q2 | 2 Million USD | 0.0% |
| 1996 Q1 | 2.3 Million USD | -11.54% |
| 1996 Q4 | 2 Million USD | -9.09% |
| 1996 Q3 | 2.2 Million USD | 10.0% |
| 1996 FY | 2 Million USD | -23.08% |
| 1996 Q2 | 2 Million USD | -13.04% |
| 1995 Q4 | 2.6 Million USD | 8.33% |
| 1995 FY | 2.6 Million USD | -13.33% |
| 1995 Q2 | 2.5 Million USD | -7.41% |
| 1995 Q3 | 2.4 Million USD | -4.0% |
| 1995 Q1 | 2.7 Million USD | -10.0% |
| 1994 Q1 | 3.1 Million USD | -11.43% |
| 1994 Q2 | 3.2 Million USD | 3.23% |
| 1994 FY | 3 Million USD | -14.29% |
| 1994 Q3 | 2.8 Million USD | -12.5% |
| 1994 Q4 | 3 Million USD | 7.14% |
| 1993 Q2 | 3.6 Million USD | -12.2% |
| 1993 Q4 | 3.5 Million USD | 0.0% |
| 1993 FY | 3.5 Million USD | -14.63% |
| 1993 Q1 | 4.1 Million USD | 0.0% |
| 1993 Q3 | 3.5 Million USD | -2.78% |
| 1992 Q3 | 4.6 Million USD | -4.17% |
| 1992 Q2 | 4.8 Million USD | 0.0% |
| 1992 Q4 | 4.1 Million USD | -10.87% |
| 1992 FY | 4.1 Million USD | -14.58% |
| 1992 Q1 | 4.8 Million USD | 0.0% |
| 1991 FY | 4.8 Million USD | 9.09% |
| 1991 Q4 | 4.8 Million USD | 9.09% |
| 1991 Q3 | 4.4 Million USD | 0.0% |
| 1991 Q2 | 4.4 Million USD | 4.76% |
| 1991 Q1 | 4.2 Million USD | -4.55% |
| 1990 Q1 | 800 Thousand USD | 60.0% |
| 1990 Q3 | 500 Thousand USD | 0.0% |
| 1990 Q4 | 4.4 Million USD | 780.0% |
| 1990 FY | 4.4 Million USD | 780.0% |
| 1989 Q4 | 500 Thousand USD | -16.67% |
| 1989 Q3 | 600 Thousand USD | 0.0% |
| 1989 FY | 500 Thousand USD | -28.57% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 94.804% |
| BrainsWay Ltd. | 15.31 Million USD | 82.611% |
| Cerus Corporation | 144.3 Million USD | 98.155% |
| Envoy Medical, Inc. | 9.4 Million USD | 71.676% |
| electroCore, Inc. | 8.94 Million USD | 70.229% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 50.15% |
| IceCure Medical Ltd | 4.24 Million USD | 37.297% |
| Inogen, Inc. | 121.38 Million USD | 97.806% |
| OrthoPediatrics Corp. | 72.56 Million USD | 96.33% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 90.998% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | 16.309% |
| MaxCyte, Inc. | 36.1 Million USD | 92.625% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -44.109% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -526.174% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.185% |
| PAVmed Inc | 57.13 Million USD | 95.339% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 89.542% |
| RxSight, Inc. | 22.18 Million USD | 87.998% |
| Sight Sciences, Inc. | 46.43 Million USD | 94.265% |
| SI-BONE, Inc. | 61.05 Million USD | 95.638% |
| TELA Bio, Inc. | 59.16 Million USD | 95.499% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 97.663% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 74.193% |
| Acutus Medical, Inc. | 54.83 Million USD | 95.144% |
| Talis Biomedical Corporation | 29.22 Million USD | 90.888% |
| Spectral AI, Inc. | 12.4 Million USD | 78.526% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 88.489% |
| CVRx, Inc. | 39.28 Million USD | 93.221% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 77.731% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -9.62% |
| Bioventus Inc. | 589.79 Million USD | 99.548% |
| Venus Concept Inc. | 107.1 Million USD | 97.514% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 94.845% |
| LivaNova PLC | 1.15 Billion USD | 99.769% |
| 908 Devices Inc. | 37.49 Million USD | 92.897% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.621% |
| Nemaura Medical Inc. | 26.37 Million USD | 89.904% |
| NeuroPace, Inc. | 86.99 Million USD | 96.939% |
| LENSAR, Inc. | 22.4 Million USD | 88.116% |
| Apyx Medical Corporation | 52.31 Million USD | 94.91% |
| Cutera, Inc. | 518.12 Million USD | 99.486% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 90.92% |
| BioSig Technologies, Inc. | 4.68 Million USD | 43.159% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 95.437% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 87.607% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.879% |
| Axonics, Inc. | 82.35 Million USD | 96.767% |
| Outset Medical, Inc. | 190.91 Million USD | 98.605% |
| IRIDEX Corporation | 24.91 Million USD | 89.311% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 97.852% |
| IRadimed Corporation | 20.73 Million USD | 87.158% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -59.08% |
| INVO Bioscience, Inc. | 19.99 Million USD | 86.682% |
| Telesis Bio, Inc. | 40.87 Million USD | 93.485% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 93.471% |
| Varex Imaging Corporation | 668.6 Million USD | 99.602% |
| Quipt Home Medical Corp. | 136.29 Million USD | 98.046% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 25.448% |
| Pulmonx Corporation | 60.63 Million USD | 95.608% |
| Dynatronics Corporation | 11.78 Million USD | 77.394% |
| Modular Medical, Inc. | 2.27 Million USD | -17.21% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 34.473% |
| Semler Scientific, Inc. | 6.27 Million USD | 57.528% |
| InMode Ltd. | 75.91 Million USD | 96.492% |
| Bruker Corporation | 2.83 Billion USD | 99.906% |
| Cytosorbents Corporation | 29.98 Million USD | 91.119% |
| DexCom, Inc. | 4.19 Billion USD | 99.937% |
| Align Technology, Inc. | 2.45 Billion USD | 99.891% |
| Viveve Medical, Inc. | 10.84 Million USD | 75.449% |
| ZimVie Inc. | 795.85 Million USD | 99.665% |
| Movano Inc. | 5.97 Million USD | 55.409% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 97.454% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -526.174% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 77.731% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.583% |
| Profound Medical Corp. | 12.66 Million USD | 78.975% |
| Insulet Corporation | 1.85 Billion USD | 99.856% |
| enVVeno Medical Corporation | 2.43 Million USD | -9.363% |
| Surmodics, Inc. | 65.82 Million USD | 95.954% |
| iCAD, Inc. | 8 Million USD | 66.717% |
| Nuwellis, Inc. | 6.78 Million USD | 60.723% |
| Biotricity, Inc. | 35.91 Million USD | 92.586% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 98.806% |
| Aethlon Medical, Inc. | 2.47 Million USD | -7.394% |
| InspireMD, Inc. | 8.14 Million USD | 67.293% |
| PAVmed Inc. | 57.13 Million USD | 95.339% |
| BIOLASE, Inc. | 35.34 Million USD | 92.466% |
| Beyond Air, Inc. | 29.77 Million USD | 91.056% |
| FONAR Corporation | 57.45 Million USD | 95.365% |
| AxoGen, Inc. | 101.16 Million USD | 97.368% |
| Vivani Medical, Inc. | 25.03 Million USD | 89.363% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 96.967% |
| Inari Medical, Inc. | 209.32 Million USD | 98.728% |
| UFP Technologies, Inc. | 118.04 Million USD | 97.744% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 79.016% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -21.831% |
| Tenon Medical, Inc. | 5.56 Million USD | 52.165% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -49.691% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 84.899% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.916% |
| Sintx Technologies, Inc. | 6.59 Million USD | 59.609% |
| NanoVibronix, Inc. | 2.68 Million USD | 0.856% |
| Quanterix Corporation | 78.08 Million USD | 96.59% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 25.448% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 45.486% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.745% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.532% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 84.037% |
| NeuroMetrix, Inc. | 1.33 Million USD | -99.756% |
| Hyperfine, Inc. | 9.8 Million USD | 72.827% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 98.936% |
| Bone Biologics Corporation | 831.4 Thousand USD | -220.302% |
| AVITA Medical, Inc. | 19.86 Million USD | 86.595% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -34.925% |
| Silk Road Medical, Inc | 114.15 Million USD | 97.667% |